Advertisement
Screener

Outset Medical, Inc. (OM) Stock Issued During Period, Value, New Issues

2.5 / 5 stars · 29/59 Roast Me

Outset Medical, Inc. Stock Issued During Period, Value, New Issues

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Outset Medical, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $4.33M.
  • Outset Medical, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $149.09M.
  • Outset Medical, Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $254.81M.
  • Outset Medical, Inc. stock issued during period, value, new issues for fiscal 2025 was $4.33M.
  • Outset Medical, Inc. stock issued during period, value, new issues for fiscal 2021 was $149.09M, a 41.49% decline from fiscal 2020.
  • Outset Medical, Inc. stock issued during period, value, new issues for fiscal 2020 was $254.81M.
Period endStock Issued During Period, Value, New Issues 3 monthStock Issued During Period, Value, New Issues 12 month
2025-12-31$4.33M
10-K · filed 2026-02-13
2025-03-31$4.33M
10-Q · filed 2026-08-06
2021-12-31$149.09M
10-K · filed 2024-02-21
2021-06-30$149.09M
10-Q · filed 2022-11-09
2020-12-31$254.81M
10-K · filed 2023-02-13
2020-09-30$254.81M
10-Q · filed 2021-11-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Vivani Medical, Inc. (VANI)United States$0.111B
Nuwellis, Inc. (NUWE)United States$0.003B